HomeAQS • CVE
add
Aequus Pharmaceuticals Inc
Previous close
$0.015
Day range
$0.015 - $0.015
Year range
$0.010 - $0.060
Market cap
1.49M CAD
Avg Volume
39.77K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 50.88K | -86.72% |
Operating expense | 846.15K | 12.44% |
Net income | -715.87K | 29.86% |
Net profit margin | -1.41K | -428.14% |
Earnings per share | — | — |
EBITDA | -809.74K | -90.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 215.05K | -27.02% |
Total assets | 1.09M | -35.78% |
Total liabilities | 5.38M | 75.16% |
Total equity | -4.29M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.50 | — |
Return on assets | -179.49% | — |
Return on capital | -318.97% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -715.87K | 29.86% |
Cash from operations | -902.11K | -102.06% |
Cash from investing | — | — |
Cash from financing | 960.29K | 1,511.63% |
Net change in cash | 58.18K | 111.31% |
Free cash flow | -714.92K | -140.68% |
About
Founded
2013
Headquarters
Website
Employees
12